The Commercial Driver Who Says It Was One Pill
Marcus, 41, is a commercial driver referred by his employer after a random urine test was positive for amphetamine. At intake he says he took one of a coworker's Adderall tablets 36 hours earlier to stay awake on a long haul and denies any other use. He reports sleeping 3–4 hours nightly for six weeks, an 8-lb weight loss, and feeling 'wired but exhausted.' AUDIT-C is 5, PHQ-9 is 14, GAD-7 is 11. He has no prior treatment, no primary care provider, and is scheduled to drive again in 48 hours. He becomes irritable when asked about his work schedule and says, 'If you write this up as abuse, I lose my job.'
1. What assessment areas should you prioritize in the first 60 minutes, and why?
Read the worked answer
Prioritize immediate safety and role functioning before diagnosis:
- Suicide/violence risk and medical stability: PHQ-9 of 14 and irritability warrant direct risk questions; stimulant crash can mimic or worsen depression.
- Substance use pattern and verification: timeline of use, dose, route, frequency, source, prescription-monitoring check, and confirmation lab. One positive screen does not establish a use disorder, but a 36-hour-old single tablet is a narrow claim.
- Withdrawal/crash risk: stimulant withdrawal is not usually medically dangerous but can involve severe fatigue, depression, and suicidal thinking.
- Co-occurring symptoms: depression, anxiety, sleep loss, weight loss, and occupational stress.
- Occupational/legal consequences: fit-for-duty status and the 48-hour driving schedule.
Reasoning: the decision is not 'does he meet criteria?' yet; it is 'what could harm him or the public in the next 48 hours?'
2. How would you reconcile the one-time-use account with the screening scores and collateral information?
Read the worked answer
Use a non-confrontational, multi-source method:
- Conduct a structured timeline follow-back for the past 90 days, asking about work shifts, sleep, appetite, and access to stimulants.
- Ask permission to contact the employer only for employment-related information and to verify the testing chain; do not disclose treatment details without a specific release.
- Request a confirmatory lab or review the existing result, including cutoff and specimen validity.
- Check the prescription monitoring program where authorized.
- Document the discrepancy factually: 'Client reports one tablet 36 hours prior; screening scores and reported symptoms suggest a longer pattern; collateral pending.'
- Avoid accusing him of lying; say the picture is incomplete and explain why more information changes the recommendation.
Reasoning: discrepant self-report is common when employment is at stake. The task is to gather data and protect the assessment's validity, not to win the discrepancy.
3. What level-of-care and referral decision is defensible before he drives again?
Read the worked answer
A defensible plan does not clear him for duty solely on self-report. It includes:
- Do not certify fitness for duty; recommend an independent fitness-for-duty or medical review, because the employer's safety-sensitive role creates a public-risk question.
- Refer for medical evaluation of sleep loss, weight loss, and possible stimulant crash, especially if depression or suicidal ideation is present.
- Recommend the least restrictive appropriate level based on DSM-5 severity and withdrawal/co-occurring risk-likely intensive outpatient with random testing and psychiatric follow-up if criteria are met, not residential by default.
- Coordinate with the employer only within the release and explain the difference between 'assessment incomplete' and 'diagnosis of abuse.'
Reasoning: the immediate risk is occupational and medical, not just diagnostic. Level of care should follow severity, withdrawal risk, co-occurring conditions, and safety, not the employer's preferred label.